Dual HER2 Blockade: An Emerging Option in Metastatic Biliary Tract Cancer?
Angela Dalia RicciAlessandro RizzoPublished in: Medicina (Kaunas, Lithuania) (2021)
Biliary tract cancer (BTC) includes a heterogeneous group of aggressive and rare hepatobiliary malignancies, including gallbladder cancer, ampullary carcinomas, intrahepatic cholangiocarcinoma (iCCA), and extrahepatic cholangiocarcinoma, further subclassified into distal (dCCA) and perihilar cholangiocarcinoma (pCCA) [...].